The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 38, No. 1, pp. 142-145. DOI 10.1345/aph.1D113
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrus, M. R
Right arrow Articles by Clark, D. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrus, M. R
Right arrow Articles by Clark, D. B

DRUG INFORMATION ROUNDS

OBJECTIFS: Évaluer la sécurité et les bénéfices cardio-vasculaires de la thérapie avec les bêta-bloquants chez les patients atteints d'une maladie pulmonaire obstructive chronique (MPOC).

SOURCE DE L'INFORMATION: Les articles pertinents ont été identifiés lors d'une recherche sur MEDLINE. Les mots-clés utilisés pour la recherche étaient chronic obstructive pulmonary disease (maladie pulmonaire obstructive chronique) et adrenergic beta-agonist (agoniste des récepteurs beta-adrénergiques).

SYNTHESE DE L'INFORMATION: Les bêta-bloquants sont fréquemment évités chez les patients avec MPOC en raison de la crainte d'un bronchospasme et ce, malgré l'importance des bénéfices potentiels de cette thérapie sur la mortalité d'origine cardio-vasculaire. Une revue des études portant sur l'utilisation des bêta-bloquants chez les patients avec MPOC a donc été entreprise.

CONCLUSIONS: Cette revue de la littérature supporte la sécurité des bêta-bloquants et leur efficacité à réduire la mortalité cardio-vasculaire chez les patients atteints de MPOC. Les patients atteints d'une MPOC légère à modérée devraient recevoir un bêta-bloquant cardio-sélectif lorsque des indications claires sont identifiées.




This article has been cited by other articles:


Home page
 ThoraxHome page
M T Dransfield, S M Rowe, J Johnson, W Bailey, and L Gerald
Authors' response
Thorax, November 1, 2008; 63(11): 1027 - 1027.
[Full Text] [PDF]

Home page
 ThoraxHome page
D. H Au
Use of {beta} blockers in patients with COPD
Thorax, April 1, 2008; 63(4): 296 - 298.
[Full Text] [PDF]

Home page
 HypertensionHome page
C. Rosendorff, H. R. Black, C. P. Cannon, B. J. Gersh, J. Gore, J. L. Izzo Jr, N. M. Kaplan, C. M. O'Connor, P. T. O'Gara, and S. Oparil
REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention
Hypertension, August 1, 2007; 50(2): e28 - e55.
[Full Text] [PDF]

Home page
 CirculationHome page
C. Rosendorff, H. R. Black, C. P. Cannon, B. J. Gersh, J. Gore, J. L. Izzo Jr, N. M. Kaplan, C. M. O'Connor, P. T. O'Gara, and S. Oparil
Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention
Circulation, May 29, 2007; 115(21): 2761 - 2788.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
H. K. Pannu, W. Alvarez Jr., and E. K. Fishman
{beta}-Blockers for Cardiac CT: A Primer for the Radiologist
Am. J. Roentgenol., June 1, 2006; 186(6_Supplement_2): S341 - S345.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. I. Rennard
Clinical Approach to Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease
Proceedings of the ATS, April 1, 2005; 2(1): 94 - 100.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Task Force Members, J. Lopez-Sendo, K. Swedberg, J. McMurray, J. Tamargo, A. P. Maggioni, H. Dargie, M. Tendera, F. Waagstein, J. Kjekshus, et al.
Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology
Eur. Heart J., August 1, 2004; 25(15): 1341 - 1362.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrus, M. R
Right arrow Articles by Clark, D. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrus, M. R
Right arrow Articles by Clark, D. B

homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.